BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31698007)

  • 1. Plasmacytoid acinar adenocarcinoma of the prostate: a newly described variant of prostate cancer.
    Al-Hussain T; Haffner MC; Altaweel WM; Epstein JI
    Hum Pathol; 2019 Dec; 94():86-91. PubMed ID: 31698007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient with prostatic adenocarcinoma with plasmacytoid features and an aberrant immunohistochemical phenotype diagnosed by biopsy and a mini-review of plasmacytoid features in the genitourinary system: A case report.
    Zacharouli K; Vageli DP; Koukoulis GK; Ioannou M
    Mol Clin Oncol; 2022 Mar; 16(3):67. PubMed ID: 35154707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic Study of Gleason Pattern 5 Prostatic Adenocarcinoma With "Single-cell" Growth Reveals 2 Distinct Types, One With "Plasmacytoid" Features.
    Nguyen JK; Chen YY; Magi-Galluzzi C; McKenney JK
    Am J Surg Pathol; 2020 Dec; 44(12):1635-1642. PubMed ID: 32991340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
    Murray SK; Breau RH; Guha AK; Gupta R
    Am J Surg Pathol; 2004 Sep; 28(9):1154-62. PubMed ID: 15316314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin A and androgen receptor positivity.
    Roudier MP; True LD; Vessella RL; Higano CS
    J Clin Pathol; 2004 Mar; 57(3):321-3. PubMed ID: 14990610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
    Compérat E
    Ann Pathol; 2017 Jun; 37(3):232-234. PubMed ID: 28554779
    [No Abstract]   [Full Text] [Related]  

  • 10. Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy.
    Dalfior D; Delahunt B; Brunelli M; Parisi A; Ficarra V; Novara G; Novella G; Gobbo S; Valotto C; Chilosi M; Menestrina F; Martignoni G
    Pathology; 2010 Jan; 42(1):1-5. PubMed ID: 20025473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary bladder metastasis of prostate cancer : a case report].
    Shirakawa H; Kozakai N; Sugiura H; Hara S
    Hinyokika Kiyo; 2010 Feb; 56(2):123-5. PubMed ID: 20186001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone.
    Roudier MP; True LD; Higano CS; Vesselle H; Ellis W; Lange P; Vessella RL
    Hum Pathol; 2003 Jul; 34(7):646-53. PubMed ID: 12874759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
    Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
    Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of completely responding stage D2 prostatic cancer with no evidence of disease 14 years after diagnosis].
    Tsuzuki M; Kawakami S; Yonese J; Ueda T; Kageyama S; Yamauchi T; Kawai T
    Hinyokika Kiyo; 1994 Sep; 40(9):837-40. PubMed ID: 7801848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature].
    Junca A; Frouin E; Irani J; Fromont G; Levillain P
    Ann Pathol; 2015 Dec; 35(6):496-501. PubMed ID: 26597142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer involving bilateral seminal vesicles along with bone and testicular metastases: a case report.
    Gao Q; Chen J; Dai Y
    J Med Case Rep; 2018 Mar; 12(1):72. PubMed ID: 29519246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleomorphic giant cell carcinoma of the prostate.
    Lopez-Beltran A; Eble JN; Bostwick DG
    Arch Pathol Lab Med; 2005 May; 129(5):683-5. PubMed ID: 15859643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer.
    Yang XJ; Lecksell K; Gaudin P; Epstein JI
    Am J Surg Pathol; 1999 Feb; 23(2):147-52. PubMed ID: 9989840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.